July 30, 2025, Beijing —— Against the backdrop of continuous advancement in pharmaceutical innovation driven by artificial intelligence technology,DP Technology and Bioduro-Sundia Officially Announce Strategic Partnership to Jointly Build an Integrated Platform for Peptide Drug Discovery, Optimization, and Evaluation Based on AI for Science (AI4S)The two parties will deeply integrate AI algorithms with chemical synthesis technology to accelerate the R&D process of novel peptide drugs such as cyclic peptides, promoting an end-to-end closed loop for new drug discovery from "design" to "delivery." With higher efficiency, better cost-effectiveness, and superior service capabilities, they will jointly serve global peptide drug R&D projects.
This collaboration deeply integrates DP Technology's technical advantages in AI and physics-based modeling for molecular design with Bioduro-Sundia's extensive experience in chemical synthesis, cell biology, and pharmacokinetics (DMPK) research, establishing an end-to-end workflow from molecular design to preclinical candidates. The platform targets various therapeutic areas, delivering high-quality cyclic peptide molecules efficiently with shorter R&D cycles and better cost-effectiveness.DP Technology accelerates AI-driven drug discovery through its self-developed Hermite® Drug Computing Platform and RiDYMO® High-Quality Lead Compound Discovery and Optimization Platform, incorporating algorithms such as Reinforced Dynamics, Uni-Dock, Uni-FEP, and Uni-QSAR. These technologies rely on high-performance computing and vast databases to comprehensively explore...A cyclic peptide compound library composed of more than 1,000 natural and non-natural amino acid combinations, with a scale exceeding one trillion.The platform rapidly filters and prioritizes molecules based on key properties such as membrane permeability, significantly accelerating the early drug discovery process and helping researchers focus their time and energy on the most promising candidate compounds.After the design is completed, Bioduro-Sundia relies on its high-throughput synthesis platform to prepare hundreds of cyclic peptides in parallel.High-purity samples that can be delivered in just one week, without additional purification and ready for bioassay. Combined with its biological detection platform, it achieves a seamless connection from computer design to experimental verification, significantly shortening the R&D cycle and reducing costs.Bioduro-Sundia CEO Armin Spura stated"We are very pleased to establish a strategic partnership with DP Technology, jointly promoting innovative peptide molecular R&D services. DP Technology has rich experience in AI-assisted drug design and optimization. We will work together to provide the industry with leading peptide drug R&D services, accelerate intelligent and efficient polypeptide drug research, and offer faster and more comprehensive solutions to customers worldwide."Wei Jie Sun, founder and CEO of DP Technology, said"Bioduro-Sundia's global professional service capabilities in the entire drug development chain, especially its extensive experience in peptide synthesis and testing, are highly complementary to DP Technology's technical advantages in AI-driven drug design. Through the deep integration of AI and experimental approaches, we are committed to jointly building an integrated platform for peptide drug discovery and evaluation, injecting new momentum into global pharmaceutical innovation and addressing more unmet clinical needs."Welcome to follow Bohr Scientific Research Space Station and SciMaster
Learn More Scientific Questions
How to Improve the Stability and Half-Life of Peptide Drugs in the Body?
What are the trends and advantages of introducing non-natural amino acids in peptide drug development?
What Impact Does the Development of Artificial Intelligence Technology Have on Peptide Drug Research and Development?
What cyclic peptide discovery technologies can be directly applied to functional screening?
Is there a green, low-cost method for peptide production?
Peptide DrugsIntellectual PropertyIs it easy to protect?
SciMaster：
https://scimaster.bohrium.com/
Bohr Scientific Research Space Station:
https://bohrium.com
Bioduro-Sundia, a portfolio company of Advent International, has 29 years of history and is a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO). Headquartered in Irvine, California, the company operates seven R&D and manufacturing centers across China and the United States, with over 2,000 employees worldwide. We focus on drug discovery, development, scale-up, and manufacturing services for both small and large molecules, offering integrated services to biotechnology and pharmaceutical companies from early target validation to commercial production, spanning multiple fields such as chemistry, biology, pharmacokinetics, active pharmaceutical ingredients (API), and finished drug products. Bioduro-Sundia specializes in CRDMO services, operating under a global quality standards system to provide advanced, rapid, and flexible customized solutions that meet the unique needs of biotech and pharmaceutical enterprises, accelerating the drug development process.DP Technology is globallyAIFor Science Leaders, AI for Science means using AI to learn a series of scientific principles and knowledge, and further solve key issues in scientific research and industrial R&D fields.Relying on deep cultivation in the field of interdisciplinary research, DP Technology has built the "Deep Potential·Universe" AI for Science large model system, further addressing key issues in scientific research and industrial development, and bringing research methods across numerous disciplines from the "experimental trial-and-error/computer" era into the "Pre-trained ModelThe "era" has formed the "innovation-implementation" chain and open ecosystem of AI for Science, built microscale industrial infrastructure based on AI for Science, empowered "thousands of industries," and created a new generation of R&D systems for the most fundamental areas of human economic development: biomedicine, energy, materials, and information science and engineering research.DP Technology is a national high-tech enterprise, nationalSpecialized, Precise, Unique, and Innovative"Little Giant" enterprises have set up R&D centers in cities such as Beijing, Shanghai, and Shenzhen.The scientific research and technology team is led by an academician of the Chinese Academy of Sciences, bringing together over a hundred outstanding young scientists and engineers from various fields such as mathematics, physics, chemistry, biology, materials, and computer science. Among the company's members, more than 35% hold a Ph.D. or are postdoctoral researchers.Core members have won the "Gordon Bell Prize," the highest award in the field of global high-performance computing in 2020. Their related work was selected as one of China's top ten scientific and technological advances in 2020 and one of the ten major technological breakthroughs in the global AI field.
'%20fill='%23FFFFFF'%3E%3Crect%20x='249'%20y='126'%20width='1'%20height='1'%3E%3C/rect%3E%3C/g%3E%3C/g%3E%3C/svg%3E)